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Introduction {#sec005}
============

Obsessive-compulsive disorder (OCD) is a common mental disorder that has a lifetime prevalence rate of 2%--3% in the general population \[[@pone.0236512.ref001]\]. OCD is characterized by recurrent intrusive thoughts and repetitive, ritualistic behaviors that negatively affect the affected person's daily life \[[@pone.0236512.ref002]\]. It is now widely accepted that abnormalities of the cortico-striatal-thalamic circuits (CSTC), particularly involving the orbitofrontal cortex, anterior cingulate cortex, thalamus and striatum, play an important role in the pathophysiology of OCD \[[@pone.0236512.ref003]\]. It was also reported that the underlying pathology is not limited to the CSTC but also involves abnormalities in additional brain systems, particularly including dorsolateral frontal and parietal regions \[[@pone.0236512.ref003]\].

Although studies using positron emission tomography (PET) or single photon emission tomography (SPECT) have been conducted to examine abnormalities of regional cerebral blood flow (rCBF) in individuals with OCD \[[@pone.0236512.ref004]--[@pone.0236512.ref013]\], the majority of these studies assessed rCBF by using regions of interest (ROI), which might generally lack efficient reproducibility and reliability \[[@pone.0236512.ref014]\]. Moreover, the ROIs used in the studies tended to lump together heterogeneous subregions with separate functional roles. With ROI-based methods, only selected portions of the brain---rather than the entire brain---are examined \[[@pone.0236512.ref007]\]. A voxel-based analysis has several advantages over the ROI-based methods \[[@pone.0236512.ref015]\]. It is an objective and automated method that can be used to investigate the functional parameters, including rCBF, of the entire brain, without the need to define anatomical boundaries.

Radioisotope examinations pose the risk of exposure to ionizing radiation. In contrast, arterial spin labeling (ASL) MRI is a noninvasive technique that can measure cerebral perfusion without radiation exposure or the use of contrast agents \[[@pone.0236512.ref016]\]. We conducted the present study to determine the differences in rCBF between patients with OCD and healthy controls by assessing the results obtained with pseudo-continuous ASL (pCASL) perfusion imaging. This modality combines the advantages of pulsed ASL and continuous ASL; pulsed ASL has relative insensitivity to magnetization transfer-related artifacts and a lower specific absorption rate, whereas continuous ASL has a higher signal-to-noise ratio (SNR) \[[@pone.0236512.ref016]\]. ASL perfusion imaging has been applied to several psychiatric diseases \[[@pone.0236512.ref017], [@pone.0236512.ref018]\], but there have been no studies that used ASL to investigate perfusion abnormalities in OCD patients.

Based on the results of prior studies, we hypothesized that the regional cerebral perfusion would differ between patients with OCD and healthy controls in regions in the CSTC, especially for the orbitofrontal cortex, anterior cingulate cortex, thalamus and striatum. The purpose of the present study was to identify abnormalities of rCBF in the CSTC as well as in other regions in OCD patients by performing a voxel-based analysis of pCASL perfusion images.

Materials and methods {#sec006}
=====================

Study population {#sec007}
----------------

This prospective observational study was approved by the Kyushu University Institutional Review Board for Clinical Research, and all recruited subjects signed an informed consent form before the study. Patients were recruited from the department of neuropsychiatry at our institution from October 2011 to August 2017. Patients fulfilling the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria for OCD based on the structured clinical interview for DSM-IV Axis I Disorders--Patient edition were selected \[[@pone.0236512.ref002]\].

The exclusion criteria were: (a) age \<20 or \>65 years; (b) pregnant; (c) current/past alcohol or drug abuse; (d) comorbid Axis I diagnosis on the above-mentioned structured clinical interview; (e) neurological or other serious physical illness; and (f) contraindications to MRI. All of the patients were medication-free for ≥4 weeks before the study. The severity of each patient's current symptoms of OCD was measured by the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) \[[@pone.0236512.ref019]\]. Healthy controls were recruited from the nearby communities. A group of healthy controls who met the exclusion criteria described above with no history of psychiatric disorders were selected. Healthy subjects who showed any obsessive-compulsive tendencies (Y-BOCS score \>0) were excluded. [Fig 1](#pone.0236512.g001){ref-type="fig"} presents a summary flowchart of the subject selection and [Table 1](#pone.0236512.t001){ref-type="table"} summarizes the demographic and clinical characteristics of the patients and healthy controls. The detailed information of the OCD patients and healthy controls are provided in [S1](#pone.0236512.s002){ref-type="supplementary-material"} and [S2](#pone.0236512.s003){ref-type="supplementary-material"} Appendices.

![Study population flowchart.](pone.0236512.g001){#pone.0236512.g001}

10.1371/journal.pone.0236512.t001

###### Demographic and clinical characteristics of the subjects.

![](pone.0236512.t001){#pone.0236512.t001g}

                          OCD (n = 23)   Healthy controls (n = 64)   p-value
  ----------------------- -------------- --------------------------- -----------------------------------------------
  Gender, male:female     9: 14          27: 37                      0.7981
  Age, yrs                37.2 ± 10.7    38.3 ± 12.8                 0.7265
  Education, yrs          12.8 ± 2.6     15.5 ± 1.8                  \<0.0001[\*](#t001fn002){ref-type="table-fn"}
  Total brain volume, L   1.15 ± 0.11    1.14 ± 0.1                  0.4949
  Illness duration, yrs   14.3 ± 12.3                                
  Y-BOCS                  22.6 ± 6.5                                 

Data are mean ± SD.

\*p \<0.05. OCD, obsessive-compulsive disorder; Y-BOCS, Yale-Brown Obsessive-Compulsive Scale.

MRI data acquisition {#sec008}
--------------------

Imaging was performed on a 3T MR system (Philips Healthcare, Best, The Netherlands) with an eight-channel head coil. High-spatial-resolution 3D T1-weighted images were acquired with a turbo field echo sequence in the sagittal plane with the following parameters: repetition time/echo time, 8.21/3.78 msec; inversion time, 1026 msec; flip angle, 8°; effective section thickness, 1.0 mm; slab thickness, 190 mm; matrix, 240 × 240; field of view, 240 × 240 mm; number of signals acquired, 1; scan duration, 5 min 23 sec. All scans resulted in 190 contiguous slices through the brain.

The imaging parameters for the pCASL experiments were as follows: single-shot gradient-echo echo planar imaging in combination with parallel imaging (sensitivity encoding factor 2.0); repetition time/echo time, 4200/8.56 msec; matrix, 64 × 64; field of view, 240 × 240 mm; in-plane resolution, 3.75 × 3.75 mm; 20 slices acquired in ascending order; slice thickness, 6 mm; slice gap, 1 mm; labeling duration, 1650 msec; post-labeling delay, 1525 msec. Forty pairs of control/label images were acquired and then averaged. The total scan duration was 5 min 44 sec. The echo planar imaging M0 images were separately obtained with the same geometry and imaging parameters as the pCASL without labeling.

Preprocessing of the data {#sec009}
-------------------------

### rCBF measurements with pCASL {#sec010}

The quantitative rCBF maps were calculated and generated from raw pCASL images and M0 images with an in-house MATLAB program using the following equation \[[@pone.0236512.ref020]\]: $$rCBF = \frac{6000 \bullet \lambda \bullet \left( {SI}_{control} - {SI}_{label} \right) \bullet e^{\frac{PLD}{{T1}_{blood}}}}{2 \bullet \alpha \bullet {T1}_{blood} \bullet {SI}_{PD} \bullet \left( 1 - e^{- \frac{\tau}{{T1}_{blood}}} \right)}\left\lbrack {{ml}/{min/100g}} \right\rbrack,$$ Where λ is the brain/blood partition coefficient in ml/g, SI~control~ and SI~label~ are the time-averaged signal intensities in the control and label images, respectively, T1~blood~ is the longitudinal relaxation time of blood in seconds, α is the labeling efficiency, SI~PD~ is the signal intensity of a proton density-weighted image, τ is the label duration, and PLD is the post-labeling delay. The parameters used in the present study were: λ = 0.9 (assumed), T1~blood~ = 1650 msec (assumed), α = 0.85 (assumed), τ = 1650 msec (calculated) and PLD = 1525 msec (calculated). The SI~PD~ was derived from the echo planar imaging M0 images.

### Preprocessing of the rCBF maps {#sec011}

The conversion from the Digital Imaging and Communications in Medicine (DICOM) format to the NifTI-1 format, the preprocessing, and the quality check of the acquired images were performed with Statistical Parametric Mapping (SPM12) software (Functional Imaging Laboratory, Wellcome Trust Centre for Neuroimaging, Institute of Neurology at University College London, UK) running on MATLAB R2016a (MathWorks Inc., Sherborn, MA).

[Fig 2](#pone.0236512.g002){ref-type="fig"} illustrates the following preprocessing steps of the rCBF maps. The generated quantitative raw rCBF maps were co-registered and resliced with the 3D T1-weighted images. This was done by first co-registering and reslicing the M0 images to the 3D T1-weighted images, and then applying the same co-registration and reslicing to the raw rCBF maps. Because M0 images retain more anatomical information than the raw rCBF maps, this process enables a more accurate co-registration of the raw rCBF maps to the 3D T1-weighted images. Next, the 3D T1-weighted images were spatially normalized to the International Consortium for Brain Mapping (ICBM) template for East Asian brains \[[@pone.0236512.ref021]\]; then, the same spatial transformation was applied to the rCBF maps, thus allowing a voxel-wise analysis of the rCBF maps in a common stereotaxic space. Because 3D T1-weighted images have more anatomical information than rCBF maps, this process enables a more accurate normalization of rCBF maps to the brain template. Finally, the rCBF maps were smoothed with a 12-mm full width at half maximum Gaussian kernel in order to decrease spatial noise and compensate for the inexactitude of normalization.

![Preprocessing steps of the rCBF maps.](pone.0236512.g002){#pone.0236512.g002}

### Preprocessing of Voxel-Based Morphometry (VBM) {#sec012}

For the preprocessing of the results of the voxel-based morphometry (VBM), first, the gray matter was segmented from 3D T1-weighted images with the use of the SPM12 program. Next, the subject's gray matter was co-registered and normalized using the diffeomorphic anatomical registration through exponentiated lie algebra (DARTEL) technique by using SPM12 software running on MATLAB R2016a. The details of the image preprocessing of VBM are described elsewhere \[[@pone.0236512.ref022]\].

Statistical analysis {#sec013}
--------------------

The statistical analyses were performed using statistical nonparametric mapping (SnPM13) software (<http://warwick.ac.uk/snpm>) \[[@pone.0236512.ref023]\], which is a toolbox of SPM12 software running on MATLAB R2016a. The nonparametric permutation approach is preferable for experimental designs implying low degrees of freedom, including small sample size problems such as between-group analyses involving small numbers of subjects \[[@pone.0236512.ref023]\]. We compared the rCBF and gray matter volume of the OCD patients and healthy controls by running 10,000 permutations, using the subjects' age, gender, and education years as nuisance covariates. An explicit mask was constructed from the average smoothed image of all of the subjects, using the SPM Masking Toolbox (<http://www0.cs.ucl.ac.uk/staff/g.ridgway/masking/>) \[[@pone.0236512.ref024]\] to restrict the statistical analyses to voxels that represent gray matter. The total brain volumes of the subjects were used as global values in the global calculation. The other parameters of the analysis were as follows: variance smoothing, 0 0 0; memory usage, high; cluster inference, none; threshold masking, none; implicit mask, yes; overall grand mean scaling, No; normalization, ANCOVA. Regression analyses investigating the relationship between the rCBF and the Y-BOCS score or the illness duration within the OCD group were performed on SnPM13 using the same parameters described above. P-values \<0.05 were considered significant, with the family-wise error rate correction for multiple comparisons. Clusters smaller than 50 voxels or located outside of the brain were excluded from the subsequent analyses.

Results {#sec014}
=======

Compared to the healthy controls, the patients with OCD showed significant rCBF reductions in the right putamen, the right frontal operculum, the left midcingulate cortex, and the right temporal pole ([Fig 3](#pone.0236512.g003){ref-type="fig"}, [Table 2](#pone.0236512.t002){ref-type="table"}). [S3 Appendix](#pone.0236512.s004){ref-type="supplementary-material"} presents the result of the ANCOVA with SnPM13 software. There were no areas with a significant rCBF elevation in the OCD patients compared to the controls. The regression analyses revealed no significant correlations between the rCBF and Y-BOCS score or illness duration in the OCD group.

![Statistical nonparametric T map of rCBF reduction in the OCD patients vs. healthy controls.\
(A) The three orthogonal planes represent a maximum intensity projection (MIP) 'glass brain'. (B--D) Selected planes show results superimposed on MNI152 T1 template. Color bar: Student's T-values. Significant reductions of rCBF are observed in the right putamen (black arrow), right frontal operculum (black arrowhead), left midcingulate cortex (white arrow), and right temporal pole (white arrowhead) in the OCD patients compared to the controls (thresholded at T \> 3.93, p\<0.05 with the family-wise error rate correction for multiple comparisons in the SnPM analysis). There were no areas of increased rCBF in the OCD patients (data not shown). rCBF, regional cerebral blood flow; OCD, obsessive-compulsive disorder; SnPM, statistical nonparametric mapping.](pone.0236512.g003){#pone.0236512.g003}
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###### Regions showing decreased rCBF in the OCD patients compared to the healthy controls.

![](pone.0236512.t002){#pone.0236512.t002g}

                           Coordinates, mm   Size, voxels   T-value         
  ------------------------ ----------------- -------------- --------- ----- ------
  R. putamen               26                −18            16        301   4.40
  R. frontal operculum     46                −8             18        92    4.44
  L. midcingulate cortex   −10               −24            48        160   4.59
  R. temporal pole         44                20             −34       176   4.36

voxel size = 2 × 2 × 2 mm^3^. R, right; L, left; rCBF, regional cerebral blood flow; OCD, obsessive-compulsive disorder.

There was no significant difference in the regional gray matter volume between the OCD patients and healthy controls.

We performed an additional ROI-based analysis for the areas that showed decreased rCBF in the voxel-based analysis described above, in order to compare the two analytical methods (for details, see [S4 Appendix](#pone.0236512.s005){ref-type="supplementary-material"}). The results of the ROI-based analysis demonstrated that the mean rCBF values within the right putamen and the right temporal pole were significantly lower in the OCD patients compared to the healthy controls; there were no significant differences in mean rCBF in the left midcingulate cortex or right frontal operculum between the groups.

Discussion {#sec015}
==========

We investigated rCBF abnormalities in drug-free OCD patients in a comparison with healthy controls by using pCASL perfusion MRI and a voxel-based image analysis. The results demonstrated reduced rCBF in the right putamen, right frontal operculum, left midcingulate cortex, and right temporal pole in the OCD patients.

Many studies using PET or SPECT have been undertaken to assess rCBF changes in OCD ([S5 Appendix](#pone.0236512.s006){ref-type="supplementary-material"}) \[[@pone.0236512.ref004]--[@pone.0236512.ref013]\], and although these studies vary regarding the number of subjects, neuroimaging modality, and analytic method, rCBF abnormalities have consistently been identified in the CSTC of OCD patients, including the orbitofrontal cortex \[[@pone.0236512.ref004], [@pone.0236512.ref007], [@pone.0236512.ref009], [@pone.0236512.ref012]\], the anterior cingulate cortex \[[@pone.0236512.ref005]--[@pone.0236512.ref007], [@pone.0236512.ref011], [@pone.0236512.ref012]\], the caudate nucleus \[[@pone.0236512.ref006], [@pone.0236512.ref010], [@pone.0236512.ref011]\], and the thalamus \[[@pone.0236512.ref006], [@pone.0236512.ref008], [@pone.0236512.ref009]\]. Our present findings are partially consistent with these reports in terms of the rCBF abnormality in the putamen observed in the OCD patients, but we observed no significant abnormalities in the other areas of the CSTC.

It is widely accepted that regional perfusion is significantly correlated with regional neuronal activity (neurovascular coupling) \[[@pone.0236512.ref025]\], and the rCBF reduction observed in the present OCD patients may therefore reflect a functional decline of these areas.

The putamen is a part of the CSTC, and it is involved in planning and execution \[[@pone.0236512.ref026]\]. A meta-analysis of functional MRI studies reported that OCD patients showed lower activation of the putamen during executive functioning compared to healthy controls \[[@pone.0236512.ref027]\]. The hypoperfusion in the putamen that we observed herein is in line with this result, considering the theory of neurovascular coupling. An ROI-based SPECT study revealed decreased rCBF in the basal ganglia of OCD patients \[[@pone.0236512.ref006]\]. On the other hand, other ROI-based SPECT studies focusing on adult OCD patients on medication \[[@pone.0236512.ref010]\] or pediatric OCD patients \[[@pone.0236512.ref011]\] reported increased rCBF in their patients' basal ganglia. We speculate that factors such as the differences in analytical method (ROI-based or voxel-based approach), medication use, and/or the patients' age could be causes of these discrepant observations. It appears that hypoperfusion in the putamen may underlie the disturbance of executive function observed in OCD.

In the present series, the OCD patients also showed foci of reduced rCBF in the medial frontal gyrus, encompassing the midcingulate cortex. The medial frontal gyrus was reported to be involved in the cognitive regulation of emotional behavior including fear and anxiety \[[@pone.0236512.ref028]\], which are core symptoms of OCD \[[@pone.0236512.ref002]\]. An extensive review of studies of cingulate neurobiology emphasized the importance of checking symptomatology in relation to the midcingulate cortex impairment \[[@pone.0236512.ref029]\]. A functional MRI study with symptom-provocation protocols suggested that hyperactivation in the midcingulate cortex was associated with checking provocation \[[@pone.0236512.ref030]\]. Regarding the rCBF at resting state, a voxel-based SPECT study described significantly lower rCBF values in the midcingulate cortex in patients with early-onset OCD compared to those of healthy controls \[[@pone.0236512.ref031]\]. Considering the above-described findings, it seems likely that the functional disturbance of the midcingulate cortex is involved in some aspects of the pathophysiology of OCD. In addition, neuronal activity or perfusion of the midcingulate cortex might dynamically change in association with checking symptoms in OCD patients.

The OCD patients in our present series also showed a focus of decreased rCBF in the frontal operculum compared to the controls. The frontal operculum correlates with resistance to compulsions in OCD patients \[[@pone.0236512.ref032]\]. A functional MRI study reported that OCD patients showed lower spontaneous brain activity in the Rolandic operculum compared to healthy controls \[[@pone.0236512.ref033]\]. Although there are no reports describing rCBF changes in this area, reduced gray matter volume was reported in a VBM study, and increased mean diffusivity in this region was also demonstrated by a diffusion tensor imaging study \[[@pone.0236512.ref034]\]. The decreased rCBF in the frontal operculum might be associated with the decline of resistance to compulsions and with the morphological and microstructural changes observed in these studies.

We observed a significant rCBF reduction in the right temporal pole in the present OCD patients. A functional MRI investigation demonstrated that the temporal pole exhibits dense functional connections to the CSTC and that it is a part of a control mechanism that down-regulates emotional saliency during the processing of emotional stimuli in healthy subjects \[[@pone.0236512.ref035]\]. In addition, OCD patients had significantly decreased functional connectivity between the temporal pole and the orbitofrontal cortex, which is a part of the CSTC \[[@pone.0236512.ref036]\]. Based on these results, we suggest that it is likely that decreased functioning of the temporal pole may cause an impaired down-regulation of emotional stimuli to the CSTC, which may be associated with the symptomatology of OCD.

In evaluations using diffusion tensor imaging (DTI), increased fractional anisotropy in the putamen \[[@pone.0236512.ref037]\] and increased mean diffusivity in the frontal operculum \[[@pone.0236512.ref034]\] were observed. These changes of the DTI parameters might reflect alterations of the underlying white matter microstructure, including fiber packing, fiber diameter, the thickness of the myelin sheaths, and the directionality of the fibers \[[@pone.0236512.ref038]\]. A composite study using ASL and DTI demonstrated a significant relationship between rCBF and the subcortical white-matter integrity assessed by fractional anisotropy and the diffusivity in healthy subjects \[[@pone.0236512.ref039]\]. The reductions of rCBF in the putamen and the operculum that we observed herein may result from the microstructural disturbance in these regions.

In the present VBM analysis, unlike many other studies, there were no significant differences in the gray matter volume between the OCD patients and healthy controls. This discrepancy may be due to the limited sample size (23 OCD patients, 64 healthy controls). Previous VBM studies with larger sample sizes reported that the changes in gray matter volume were found in the areas that are similar or adjacent to those in which the present ASL analysis showed rCBF reduction, i.e., the medial prefrontal cortex, cingulate cortex, and insula \[[@pone.0236512.ref040], [@pone.0236512.ref041]\]. Considering these findings, we speculate that the ASL could sensitively detect physiologically impaired areas without structural abnormalities even in the present small sample size.

We also observed that there was no area where the rCBF was significantly correlated with the Y-BOCS score, whereas other investigations demonstrated positive correlations between symptom severity and the rCBF in the CSTC \[[@pone.0236512.ref007], [@pone.0236512.ref009], [@pone.0236512.ref010]\]. This discrepancy indicates that cerebral perfusion changes do not invariably correlate with symptom severity in OCD. Although it has been reported that the duration of illness affects the volume of the striatal areas, medial frontal, orbitofrontal, and insulo-opercular areas in patients with OCD \[[@pone.0236512.ref042]\], we observed no significant correlations between rCBF and the illness duration in the present study. The negative results for Y-BOCS and illness duration shown herein may be due to the highly heterogeneous nature of OCD \[[@pone.0236512.ref043]\].

Two analytical methods have been used to assess rCBF abnormalities in OCD patients in prior investigations: an ROI-based approach or a voxel-based approach \[[@pone.0236512.ref004]--[@pone.0236512.ref013]\]. We performed an ROI-based analysis in addition to the main voxel-based analysis in order to compare the two analytical methods, and the results demonstrated that the ROI-based analysis failed to detect rCBF decreases in the right frontal operculum and the left midcingulate cortex. This might have occurred because the ROIs lumped together large heterogeneous subregions with separate functional roles, with the results that small foci of decreased rCBF were missed. It therefore appears that the voxel-based approach has an advantage over the ROI-based approach in detecting smaller areas with rCBF abnormality.

The absence of significant findings involving other areas of the CSTC in the present patients was unexpected, since many studies have reported the presence of rCBF alterations in the CSTC \[[@pone.0236512.ref004]--[@pone.0236512.ref013]\]. It is possible that the discrepancy between our findings and previous findings is related to unknown differences in clinical characteristics of the patients studied.

Our study has several limitations, the first of which is the small sample size. Second, there was a significant difference in the years of education between the OCD and control groups. It was unclear whether the observed differences persisted and affected the results even after adjustment for years of education. Third, we used the PLD of 1525 msec for the pCASL, and this value is shorter compared to the recommendation in the consensus paper published by the MR perfusion community \[[@pone.0236512.ref020]\], i.e., the PLD of 1800 msec for adults \<70 years old. However, since our present subjects were relatively young (OCD: mean 37.2 yrs, controls: mean 38.3 yrs), we believe that the PLD of 1525 msec was not too short. Fourth, ASL using echo planar imaging inevitably suffers from susceptibility artifacts (particularly in mesial temporal regions) due to the proximity of the skull base and air-containing structures \[[@pone.0236512.ref044]\]. Distortions of pCASL images in these regions might have led to a low SNR to some extent; however, as we focused on the between-group differences in quantitative rCBF maps rather than conducting a direct analysis of raw pCASL images, we think that the SNR of the raw pCASL images did not critically affect the final results. Last, a DTI analysis was not performed. For the further clarification of the pathophysiology of OCD from various perspectives, a composite study including ASL, VBM, and DTI analyses is needed.

Conclusion {#sec016}
==========

Our findings demonstrated that ASL perfusion imaging could noninvasively detect physiologically impaired areas without structural abnormalities in OCD patients. Our pCASL-based study using a voxel-based analysis revealed hypoperfusion in the right putamen, right frontal operculum, and left midcingulate cortex of OCD patients. The rCBF reductions observed in these regions may be associated with the pathophysiology of OCD.
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======================

###### 

(TIFF)

###### 

Click here for additional data file.

###### The detailed information of the OCD patients.

(XLSX)

###### 

Click here for additional data file.

###### The detailed information of healthy controls.

(XLSX)

###### 

Click here for additional data file.

###### The result of the ANCOVA with SnPM13 software

(TIF)

###### 

Click here for additional data file.

###### The detailed information of the additional ROI-based analysis.

(DOCX)

###### 

Click here for additional data file.

###### Previous studies showing rCBF changes in OCD patients.

(XLSX)

###### 

Click here for additional data file.

ASL

:   arterial spin labeling

CSTC

:   cortico-striatal-thalamic circuits

OCD

:   obsessive-compulsive disorder

pCASL

:   pseudo-continuous arterial spin labeling

rCBF

:   regional cerebral blood flow

ROI

:   region of interest

SPM

:   statistical parametric mapping

VBM

:   voxel-based morphometry

Y-BOCS

:   Yale-Brown Obsessive Compulsive Scale

10.1371/journal.pone.0236512.r001

Decision Letter 0

Chen

Xi

Academic Editor

© 2020 Xi Chen

2020

Xi Chen

This is an open access article distributed under the terms of the

Creative Commons Attribution License

, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

6 May 2020

PONE-D-20-05758

A voxel-based analysis of cerebral blood flow abnormalities in obsessive-compulsive disorder using pseudo-continuous arterial spin labeling MRI A cerebral blood flow analysis of obsessive-compulsive disorder using MRI

PLOS ONE

Dear Dr. Momosaka,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We would appreciate receiving your revised manuscript by Jun 20 2020 11:59PM. When you are ready to submit your revision, log on to <https://www.editorialmanager.com/pone/> and select the \'Submissions Needing Revision\' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: <http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols>

Please include the following items when submitting your revised manuscript:

A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled \'Response to Reviewers\'.A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled \'Revised Manuscript with Track Changes\'.An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled \'Manuscript\'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Xi Chen

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1\. Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at

<https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf> and

<https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

2\. Please amend either the title on the online submission form (via Edit Submission) or the title in the manuscript so that they are identical.

\[Note: HTML markup is below. Please do not edit.\]

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: No

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: Momosaka and colleagues identified regions of frontal operculum, midcingulate cortex and putamen with lower rCBF in OCD patients using ASL imaging. Moreover, these significant brain regions mostly targeted in the cortico-striatal-thalamic circuit, which provides more evidence of CSTC physiological disruption through ASL modality. It\'s a very interesting study. The analysis methods appeared to be sound and thus the group differences are very robust. I also have a couple of additional suggestions to improve this manuscript.

Major comments:

1, In the inclusion criteria of OCD patients, the authors did not mention whether the patients have the comorbidity of depression and anxiety symptoms, as comorbidity issue is very common in the clinically psychiatric diagnosis. The author should at least address this point. If yes, whether this comorbidity could have an impact on the results.

2, The authors reported the results of both nonparametric and parametric tests. I think nonparametric results are good enough to illustrate the main findings of this study and more strict to identify the abnormal regions in OCD in this paper. So, I would suggest to remove the results of parametric results.

3, In the introduction, the author mentioned higher signal-to-noise ratio in the pCASL, which could be helpful to sensitively detect the brain abnormalities in OCD. Moreover, they found lower rCBF in the regions of the temporal pole and frontal operculum, which is in or very close to the regions with lower signal-to-noise ratio in the neuroimaging correction. Could the authors test the effect of SNR among these regions showing between-group differences?

4, In the discussion, the authors could add more discussion about the relationship between decreased rCBF and its associated disrupted pathophysiology of OCD. In other words, why does OCD show decreases of rCBF, rather than increased rCBF? What does lower rCBF imply in the links with the symptomatology of OCD?

Minor comments:

1, In the abstract, the authors said the alterations of cerebral perfusion may precede structrual changes in OCD, which does not make sense and is not rigorous. The authors did not have longitudinal results to support this point. It\'s very difficult to make a conclusion of the order of functional and structural changes for the current results. The authors could just say there is no structural changes in OCD while physiological disruption occurs in OCD patients. Thus, I would suggest to remove this kind of description in the manuscript.

2, In the Methods, the authors did not mention the resample of neuroimaging. Resample to 3\*3\*3?

3, Even though the authors regressed out total brain volume in the between-group comparisons of rCBF, they should report the results of between-group comparison of total brain volume before they do the VBM analysis. Because sometimes structural changes did not meet the multiple testing in voxel-level analysis, while it could have subtle changes in the global or regional level.

4, In the Methods, the authors run the nonparametric analysis with 5000-time permutation. Why not choose 10000 permutations, which is more commonly used.

Reviewer \#2: This paper proposes to identify abnormalities of regional cerebral blood flow (rCBF) in obsessive compulsive disorder (OCD) patients by means of a voxel-based analysis of pseudo continuous arterial spin labeling (pCASL) perfusion images. A study of 23 OCD patients and 64 health controls is conducted by performing a patient recruitment, MRI data acquisition, data preprocessing, Voxel-based morphometry and statistical analysis. The results and discussion are included to show that the rCBF reductions in these regions observed in OCD patients could be associated with the pathophysiology of OCD.

Overall this is an interesting paper that studies an important topic in rCBF analysis of OCD patients. The author novelly proposed to use the entire brain analysis instead of ROI-based methods. Essential research protocols and experiments are set up to study the subjects. The pseudo-continuous ASL (pCASL) perfusion imaging technique is used for MRI to capture and examine the difference in rCBF between patients and healthy controls. In the statistical analysis and discussion, a concrete observation and precise conclusion is summarized with enough discussion about limitation.

From the application and study perspective, this paper proposes a good method in medical field with sufficient experiment details. However, there are several points that can be further improved:

\* The data is not clearly explained and published, which may violate the PLOS Data policy. It\'s suggested to give a location of the data used and made it public available. Specifically, the statistic analysis part doesn\'t give a detail about data points, there is only limited summary and overview.

\* The experiment is a little bit weak to support the effectiveness of proposed approach. It\'s suggested to compare the results with other baseline approaches (for example, ROI-based approach). Such comparison will make it more clear to readers and highlights the improvement over other existing methods.

Overall this is an interesting paper, I recommend the author to further improve this paper and address above issues to make it better.

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files to be viewed.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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Reviewer \#1:

Major comments:

1, In the inclusion criteria of OCD patients, the authors did not mention whether the patients have the comorbidity of depression and anxiety symptoms, as comorbidity issue is very common in the clinically psychiatric diagnosis. The author should at least address this point. If yes, whether this comorbidity could have an impact on the results.

Response: In this study, we excluded OCD patients with a comorbid axis I diagnosis (including mood and anxiety disorders) by using the structured clinical interview for the DSM-IV axis I disorders, patient edition (p.8, lines 99-102). Thus, none of the OCD patients in this study had any comorbid axis I disorders.

2, The authors reported the results of both nonparametric and parametric tests. I think nonparametric results are good enough to illustrate the main findings of this study and more strict to identify the abnormal regions in OCD in this paper. So, I would suggest to remove the results of parametric results.

Response: We have removed the results for the parametric analyses as suggested. All analyses including the comparison of rCBF and gray matter volume between the OCD patients and healthy controls and the regression analysis within the OCD patients used the nonparametric test. The results obtained with the nonparametric test were the same as those obtained with the parametric test.

3, In the introduction, the author mentioned higher signal-to-noise ratio in the pCASL, which could be helpful to sensitively detect the brain abnormalities in OCD. Moreover, they found lower rCBF in the regions of the temporal pole and frontal operculum, which is in or very close to the regions with lower signal-to-noise ratio in the neuroimaging correction. Could the authors test the effect of SNR among these regions showing between-group differences?

Response: In general, ASL using EPI inevitably suffers from susceptibility artifacts in mesial temporal regions due to the proximity of the skull base and air-containing structures (Petcharunpaisan et al., World J Radiol 2010;2). Distortions of raw pCASL images in regions of high magnetic field susceptibility may lead to a low signal-to-noise ratio (SNR) to some extent; we have therefore measured SNRs within the circular region-of-interest (ROI) placed on the right temporal pole and the right frontal operculum on the label images of the pCASL in all subjects. The SNR was also measured in the right cerebellar hemisphere as a reference.

We calculated the SNRs by using the following formula (Yu et al., BMC Medical Imaging 2018;18):

SNR=0.655 × μ_tissue⁄σ_air

where μ_tissue is the mean signal intensity within the ROI positioned on each area of the brain, and σ_air is the standard deviation of the signal intensity within the ROI placed on the air.

As a result, the SNR in the right temporal pole was high enough, and there was no major difference in mean SNR between the right temporal pole and the right cerebellar hemisphere (175.8 ± 104.3 vs. 214.0 ± 124.5).

In addition, as we did not directly analyze raw pCASL images but rather focused on the between-group differences in quantitative rCBF maps, we think that the SNR of the raw pCASL image doesn't critically affect the final results. However, since the SNR of the right temporal lobe was a little lower in fact, we have added this issue to the limitation section of the Discussion (p. 23-24, line 348-354).

The SNR of the right frontal operculum was also high enough and not lower than that of the right cerebellar hemisphere (358.8 ± 260.0 vs. 214.0 ± 124.5).

4, In the discussion, the authors could add more discussion about the relationship between decreased rCBF and its associated disrupted pathophysiology of OCD. In other words, why does OCD show decreases of rCBF, rather than increased rCBF? What does lower rCBF imply in the links with the symptomatology of OCD?

Response: Considering the neurovascular coupling theory, the reduction in rCBF shown in the present study might reflect functional decline of the corresponding areas. We have clarified this point throughout the Discussion section and more thoroughly discussed the relationships between the functional decline of the areas detected in the present study and the symptomatology of OCD, referencing previous functional MRI studies (p.17-20, 252-299).

Minor comments:

1, In the abstract, the authors said the alterations of cerebral perfusion may precede structrual changes in OCD, which does not make sense and is not rigorous. The authors did not have longitudinal results to support this point. It\'s very difficult to make a conclusion of the order of functional and structural changes for the current results. The authors could just say there is no structural changes in OCD while physiological disruption occurs in OCD patients. Thus, I would suggest to remove this kind of description in the manuscript.

Response: We have removed the description about the order of functional and structural changes. Instead, we concluded as follows: it was possible that the ASL could sensitively detect physiologically impaired areas without structural abnormalities even in the small sample size (p.21, line 315-317).

2, In the Methods, the authors did not mention the resample of neuroimaging. Resample to 3\*3\*3?

Response: Thank you for pointing this out. In the present study, the rCBF maps were first resampled to 1�1�1 mm. Specifically, the M0 images are co-registered and resampled to the 3D T1WIs with 1�1�1 mm resolution; then, the same transformations were applied to the raw rCBF maps. After the normalization to the brain template and smoothing, the resolution was finally changed to 2�2�2 mm. We have added a new Fig 2 which illustrates the details of the preprocessing steps applied to the pCASL maps.

3, Even though the authors regressed out total brain volume in the between-group comparisons of rCBF, they should report the results of between-group comparison of total brain volume before they do the VBM analysis. Because sometimes structural changes did not meet the multiple testing in voxel-level analysis, while it could have subtle changes in the global or regional level.

Response: Thank you for this suggestion. We have compared the total brain volume between the OCD patients and healthy controls and confirmed that there was no significant difference. We have added this result to Table 1. In addition, detailed subjects' information including total brain volume has been added as supplemental data (S1 and S2 Appendices).

4, In the Methods, the authors run the nonparametric analysis with 5000-time permutation. Why not choose 10000 permutations, which is more commonly used.

Response: We have re-calculated all nonparametric analyses with 10,000-time permutations. The main findings are identical. We have replaced the previous 5,000-permuations results with the new results with 10,000-time permutations.

Reviewer \#2:

The data is not clearly explained and published, which may violate the PLOS Data policy. It\'s suggested to give a location of the data used and made it public available. Specifically, the statistic analysis part doesn\'t give a detail about data points, there is only limited summary and overview.

Response: We have added the subjects\' detailed information including individual age, gender, education years, total brain volume, illness duration, and Y-BOCS score as supplemental data (S1 and S2 Appendices). The raw results of the rCBF comparison between the OCD patients and healthy controls acquired by using SnPM13 were also added as S3 Appendix.

Regarding the statistical analysis section, we have added descriptions of the analytical methods, tools and parameters in as much detail as possible (p.13-14, line 179-198).

The experiment is a little bit weak to support the effectiveness of proposed approach. It\'s suggested to compare the results with other baseline approaches (for example, ROI-based approach). Such comparison will make it more clear to readers and highlights the improvement over other existing methods.

Response: We have performed an ROI-based analysis in addition to the main voxel-based analysis in order to compare the analytical methods. The ROI-based analysis was performed focusing on the areas corresponding to the right putamen, the right frontal operculum, the left midcingulate cortex, and the right temporal pole, which demonstrated significant rCBF reductions in the OCD patients compared to the healthy controls in the voxel-based analysis. The detailed information of the additional ROI-based analysis is provided as Appendix S4.

The ROI-based analysis detected a reduction of the rCBF in the areas corresponding to the right putamen and right temporal pole; however, it failed to detect an rCBF reduction in the right frontal operculum or the left midcingulate cortex (p.16, line 231-237). This might be because the ROIs gathered together large heterogeneous subregions with separate functional roles, resulting in the missing of small foci of decreased rCBF. Thus, it seems that the voxel-based approach has an advantage over the ROI-based approach in detecting smaller areas with rCBF abnormalities. We have added this description to the Discussion (p.22-23, line 327-335).
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1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#1: All comments have been addressed

Reviewer \#2: All comments have been addressed

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

Reviewer \#2: Yes
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3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: Yes
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5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes
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6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: All the points that I mentioned have been well addressed. A good paper to identify some interesting regions associated with OCD in ASL.

Reviewer \#2: The revised version addressed the major and minor issues in the comments. Specifically, more descriptions about dataset are included in the article with supplement materials. In additional, a ROI-based analysis is added with sufficient details in the statistical analysis and discussion. Some of the key points and questions are also answered and reflected in the corresponding section to be more concise and convincing. I would suggest to accept this paper for publishing.
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7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No
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10.1371/journal.pone.0236512.r004

Acceptance letter

Chen

Xi

Academic Editor

© 2020 Xi Chen

2020

Xi Chen

This is an open access article distributed under the terms of the

Creative Commons Attribution License

, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

14 Jul 2020

PONE-D-20-05758R1

A voxel-based analysis of cerebral blood flow abnormalities in obsessive-compulsive disorder using pseudo-continuous arterial spin labeling MRI

Dear Dr. Momosaka:

I\'m pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they\'ll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.

If we can help with anything else, please email us at <plosone@plos.org>.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Xi Chen

Academic Editor

PLOS ONE

[^1]: **Competing Interests:**We have declared that no competing interests exist.
